BOTHELL, Wash., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2025, ...

The course offers key market opportunities by enabling senior managers to effectively navigate US FDA regulations, strategize applications for NDAs and generics, and understand biologics processes. It ...

Samjong KPMG announced on the 14th that it had signed a Memorandum of Understanding (MOU) with Pathway Partners at the ...

Commercially Launched ORLYNVAH™ in the United States in August 2025-- --Extended Cash Runway into Q2 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, Nov. 14, ...

Fall 2025, a new conference focusing on collaborations and innovative discoveries in pharmacology, InnoPharm, was held in San ...

Explore the Wasatch U.S. Select Fund's Q3 2025 results, including underperformance vs. its benchmark and analysis of key ...

Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Greetings, and welcome to the Pelthos Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please ...

Scientists at the University of Oxford, have identified how rare populations of abnormal cells drive the formation and ...

Q3 2025 Earnings Call November 13, 2025 9:00 AM ESTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

The report offers opportunities to identify key business strategies and locations for clinical trials in Social Anxiety Disorder, highlighting enrollment trends, trial success rates, and prominent ...

Detailed price information for Benitec Biopharma Ltd ADR (BNTC-Q) from The Globe and Mail including charting and trades.